Costa Rogério A, Farah Michel E, Cardillo José A, Calucci Daniela, Williams George A
IPEPO, Instituto da Visão, Department of Ophthalmology, Federal University of São Paulo, Brazil.
Retina. 2003 Apr;23(2):159-65. doi: 10.1097/00006982-200304000-00004.
To better understand the mechanisms of action of photodynamic therapy (PDT) with verteporfin for subfoveal choroidal neovascularization (CNV), the authors evaluated the retinal and choroidal response immediately after treatment with serial optical coherence tomography (OCT) and indocyanine green angiography (ICGA).
This study was a prospective, noncomparative case series. PDT was performed on nine eyes of nine consecutive patients who presented with subfoveal CNV due to age-related macular degeneration, and serial evaluation with OCT as well as ICGA was performed at 20-minute intervals for the first 2 hours and then at 1 week, 1 month, and 3 months.
In the first 2 hours after PDT, OCT showed an increase in the thickness of the retina in the treatment area due to fluid leakage from the neovascular complex as confirmed by ICGA. At 1 week, marked reduction of intraretinal/subretinal fluid was observed in all patients. Neovascular complex nonperfusion by ICGA was associated with some degree of choroidal hypoperfusion in the treatment area. Return of the foveal contour by OCT was optimal after 1 month of treatment. At 3 months, choroidal reperfusion by ICGA and recurrent intraretinal/subretinal fluid by OCT were observed.
Serial OCT and ICGA evaluation after PDT suggests that the initial successful CNV nonperfusion as shown by fluorescein angiography at 1 week occurs by means of selective PDT damage to the lesion and/or reduced choroidal blood flow in the treatment area, thereby decreasing intraretinal/subretinal fluid and facilitating restoration of the retinal architecture.
为了更好地理解维替泊芬光动力疗法(PDT)治疗黄斑下脉络膜新生血管(CNV)的作用机制,作者通过连续光学相干断层扫描(OCT)和吲哚菁绿血管造影(ICGA)评估了治疗后即刻的视网膜和脉络膜反应。
本研究为前瞻性、非对照病例系列。对9例因年龄相关性黄斑变性导致黄斑下CNV的连续患者的9只眼进行了PDT治疗,并在最初2小时内每隔20分钟进行一次OCT以及ICGA的连续评估,随后在1周、1个月和3个月时进行评估。
PDT治疗后的最初2小时内,OCT显示治疗区域视网膜厚度增加,这是由于ICGA证实的新生血管复合体渗漏液体所致。在1周时,所有患者均观察到视网膜内/视网膜下液明显减少。ICGA显示新生血管复合体无灌注与治疗区域一定程度的脉络膜灌注不足相关。治疗1个月后,OCT显示黄斑轮廓恢复最佳。在3个月时,观察到ICGA显示脉络膜再灌注以及OCT显示视网膜内/视网膜下液复发。
PDT治疗后进行连续OCT和ICGA评估表明,1周时荧光素血管造影显示的最初成功的CNV无灌注是通过PDT对病变的选择性损伤和/或治疗区域脉络膜血流减少实现的,从而减少视网膜内/视网膜下液并促进视网膜结构的恢复。